Vasospastic Angina Clinical Trial
Official title:
Identification of the Key Factors Increasing the Risk of Vasospastic Angina Based on Multi-omics.
This is a observational study to identify the key factor associated with vasospastic angina and to explore the prognosis of the participants. The study will recruit 400 patients with vasospastic angina, 400 healthy controls and 400 patients with acute myocardial infarction. Next generation sequencing, metabolome and proteomics will be performed in these participants.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04827498 -
Myocardial Ischemia Without Obstructive Coronary Stenoses
|
||
Completed |
NCT02087007 -
A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina
|
Phase 3 | |
Recruiting |
NCT05294887 -
Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease
|
Phase 4 | |
Recruiting |
NCT06401291 -
Transcutaneous Electrical Nerve Stimulation in Patients With Angina and Non-Obstructive Coronary Arteries
|
N/A | |
Recruiting |
NCT05313919 -
Coronary Microcirculatory Disease and Inflammation in Patients With Chronic Coronary Syndrome and no Significant Coronary Artery Stenosis
|
||
Not yet recruiting |
NCT06424834 -
Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06415227 -
The Impact of Vericiguat on Microvascular Function in Patients With Documented Vasospastic Angina Pectoris
|
Phase 2 | |
Recruiting |
NCT04674449 -
iCorMicA - Stratified Medicine in Angina
|
N/A | |
Completed |
NCT02094469 -
Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina
|
Phase 3 | |
Recruiting |
NCT02180971 -
Multidetector Coronary CT In Vasospastic Angina
|
N/A | |
Completed |
NCT00602017 -
Bioequivalency Study of Amlodipine Tablets Under Fasting Conditions
|
N/A | |
Completed |
NCT00601302 -
Bioequivalency Study of Amlodipine Tablets Under Fed Conditions
|
N/A |